PRMT5 as a druggable target for glioblastoma therapy

Author:

Banasavadi-Siddegowda Yeshavanth Kumar12,Welker Alessandra M345,An Min3,Yang Xiaozhi6,Zhou Wei7,Shi Guqin8,Imitola Jaime9,Li Chenglong678,Hsu Sigmund1,Wang Jiang10,Phelps Mitch10,Zhang Jianying11,Beattie Christine E3,Baiocchi Robert12,Kaur Balveen12

Affiliation:

1. The Vivian L. Smith Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas

2. Department of Neurological Surgery, College of Medicine, The Ohio State University, Columbus, Ohio

3. Department of Neuroscience, College of Medicine, The Ohio State University, Columbus, Ohio

4. Department of Pathology, Center of Cancer Research, Massachusetts General Hospital, Boston, Massachusetts

5. Harvard Stem Cell Institute, Boston, Massachusetts

6. Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida

7. Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida

8. Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio

9. Laboratory for Neural Stem Cells and Functional Neurogenetics, Division of Neuroimmunology and Multiple Sclerosis, Departments of Neurology and Neuroscience, College of Medicine, The Ohio State University, Columbus, Ohio

10. Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio

11. Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio

12. College of Medicine, Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Function of serine/arginine-rich splicing factors in hematopoiesis and hematopoietic malignancies;Cancer Cell International;2024-07-21

2. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model;International Journal of Molecular Sciences;2024-05-15

3. Zebrafish live imaging: a strong weapon in anticancer drug discovery and development;Clinical and Translational Oncology;2024-03-21

4. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers;International Journal of Molecular Sciences;2024-03-06

5. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3